Behavioral cross-tolerance between repeated intracerebellar nicotine and acute Δ9-tetrahydrocannabinol-induced cerebellar ataxia: Role of cerebellar nitric oxide

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 1, 2007, Pages 243-253

  Smith, Aaron D ^a   Dar, M Saeed ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; DRONABINOL; HEXAMETHONIUM; N METHYL 4 (3 PYRIDINYL) 3 BUTENAMINE; NICOTINE; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBELLAR ATAXIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CEREBELLAR ATAXIA; CEREBELLUM; DIHYDRO-BETA-ERYTHROIDINE; DRUG TOLERANCE; HEXAMETHONIUM; MALE; MICE; NICOTINE; NITRIC OXIDE; TETRAHYDROCANNABINOL;

EID: 34250786712     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.120634     Document Type: Article

References (28)

1. 9-THC-induced central nervous system effects in the mouse. Eur J Neurosci 13:561-568.
2. 9-Tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur J Neurosci 20:2737-2748.
3. Castañé A, Valjent E, Ledent C, Parmentier M, Maldonado R, and Valverde O (2002) Lack of CB1 cannabinoid receptors modifies nicotine behavioral responses, but not nicotine abstinence. Neuropharmacology 43:857-867.
4. Dar MS, Bowman ER, and Li C (1994) Intracerebellar nicotinic-cholinergic participation in the cerebellar adenosinergic modulation of ethanol-induced motor incoordination in mice. Brain Res 644:117-127.
5. Dar MS, Mustafa SJ, and Wooles WR (1983) Possible role of adenosine in the CNS effects of ethanol. Life Sci 33:1363-1374.
6. Fernandez-Cancio EM and Fernandez-Vitos JJ (2001) Sources of interference in the use of 2,3-diaminonaphthalene for the fluorimetric determination of nitric oxide synthase activity in biological samples. Clin Chim Acta 312:205-212.
7. 14C] nicotine. Drug Metab Dispos 27:1448-1455.
8. Hartell NA, Furuya S, Jacoby S, and Okada D (2001) Intracellular action of nitric oxide increases cGMP in cerebellar Purkinje cells. Neuroreport 12:25-28.
9. 1 cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. FEBS Lett 459:277-281.
10. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
11. 9- tetrahydrocannabinol in rats. Behav Pharmacol 17:195-199.
12. Lévénés C, Daniel H, Soubrie P, and Crepel F (1998) Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J Physiol 510:867-879.
13. 3H]-labeled adenosine agonist/antagonist following their intrastriatal microinfusion. Methods Find Exp Clin Pharmacol 18:373-386.
14. Misko TP, Schilling RJ, Salvemini D, Moore WM, and Currie MG (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214:11-16.
15. Penetar DM, Kouri EM, Gross MM, McCarthy EM, Rhee CK, Peters EN, and Lukas SE (2005) Transdermal nicotine alters some of marihuana's effects in male and female volunteers. Drug Alcohol Depend 79:211-223.
16. Pogun S, Demirgoren S, Taskiran D, Kanit L, Yilmaz O, and Koylu EO (2000) Nicotine modulates nitric oxide in rat brain. Eur Neuropsychopharmacol 10:463-472.
17. Rao AM, Dogan A, Hatcher JF, and Dempsey RJ (1998) Fluorometric assay of nitrite and nitrate in brain tissue after traumatic brain injury and cerebral ischemia. Brain Res 793:265-270.
18. Seo DO and Rivier DO (2003) Interaction between alcohol and nitric oxide on ACTH release in the rat. Alcohol Clin Exp Res 27:989-996.
19. Shim I, Kim HT, Kim YH, Chun BG, Hahm DH, and Lee EH (2002) Role of nitric oxide synthase inhibitors and NMDA receptor antagonists in nicotine-induced behavioral sensitization in the rat. Eur J Pharmacol 443:119-124.
20. Simmons MS and Tashkin DP (1995) The relationship of tobacco and marijuana smoking characteristics. Life Sci 56:2185-2191.
21. Slotnick BM and Leonard CM (1975) A Stereotaxic Atlas of Albino Mouse Forebrain, United States Government Printing Office, Washington, DC
22. 2 subtype. Brain Res 1115:16-25.
23. 9-THC cerebellar ataxia: role of cerebellar nitric oxide. Pharmacol Biochem Behav 86:103-112.
24. Smith DA, Hoffmann GA, David DJ, Adams CE, and Gerhardt GA (1998) Nicotine-evoked NO release in the rat hippocampal slice. Neurosci Lett 255:127-130.
25. 11C]RJR-2403, a nicotinic agonist. J Labeled Comp Radiopharm 44:425-436.
26. Vincent SR, Williams JA, Reiner PB, and El-Husseini AD (1998) Monitoring neuronal NO release in vivo in cerebellum, thalamus and hippocampus. Prog Brain Res 118:27-35.
27. Wazlawik E and Morato GS (2003) Influence of drugs acting on nitric oxide-dependent pathways on ethanol tolerance in rats. Psychopharmacology (Berl) 170:343-350.
28. Watson SJ, Benson JA, and Joy JE (2000) Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Arch Gen Psychiatry 57:547-552.